May 28th, 2026
The Apolipoprotein E (APOE) gene exhibits a small number of common sequence variants across the human population, of which the desirable APOE2 variant is associated with modestly greater longevity, and the undesirable APOE4 variant is associated with a sizable increase in the risk of Alzheimer's disease. APOE is one of only a few genes to exhibit a reliable correlation with human life expectancy that replicates in epidemiological data from multiple study populations. APOE is involved in the transport of lipids, particularly cholesterol, as a component part of different forms of transport particle that carry these molecules around the body, such as low density lipoprotein (LDL) particles. In this context it is important to note that the lipid manufacture and transport systems of the brain are somewhat distinct from those of the body, and APOE is involved separately on both sides of the blood-brain barrier.
Investigations into how exactly APOE variants affect Alzheimer's disease risk and progression have focused on lipid metabolism. It seems likely that APOE may have roles inside the cell as well as outside the cell, as few proteins have only a single function. Those roles are not well understood, however. A body of evidence links APOE to inflammatory behavior in immune cells, such as microglia in the brain, but it is not settled as to how exactly this emerges from or interacts with its role in lipid metabolism, or whether it is entirely distinct. To further complicate matters, today's open access paper provides cell culture data to show that APOE2 appears to reduce DNA damage and cellular senescence in neurons. The authors do not offer any mechanistic interpretation of this data, it is an observation only. It is definitely unclear as to how this outcome emerges given what is known of APOE.
